"Systemic Tx Offers Better Outcomes in Severe Uveitis" - Kristin Jenkins
Systemic therapy with oral corticosteroids and immunosuppression preserved vision better over the long term than regional implant therapy in patients with severe uveitis, according to a 7-year follow-up study. "The clinical implications based on these results is that for many patients – probably most – systemic therapy would be a better choice," noted co-author Douglas Jabs, MD, MBA, director, Mount Sinai New York Eye and Ear Vision Institute at The Mount Sinai Hospital, told MedPage Today. "They have better visual outcomes long-term, fewer ocular side effects, and no apparent significant increase in the risk of systemic side effects, except for the greater use of antibiotics.:
- Douglas A. Jabs, MD, MBA, Professor, Ophthalmology, Medicine, Icahn School of Medicine at Mount Sinai, Director, Uveitis Division, Mount Sinai Hospital, Director, Mount Sinai/NewYork Eye and Ear Vision Research Institute
Additional Coverage:
News Medical
Medical Express
Blinding Eye Disease Strongly Associated With Serious Forms of Cardiovascular Disease
Nov 17, 2022 View All Press Releases
High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma
Aug 02, 2022 View All Press Releases
Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke
Jul 12, 2022 View All Press Releases